Brokerages predict that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce earnings per share of $0.63 for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for U.S. Physical Therapy’s earnings, with the highest EPS estimate coming in at $0.64 and the lowest estimate coming in at $0.62. U.S. Physical Therapy posted earnings per share of $0.49 during the same quarter last year, which suggests a positive year over year growth rate of 28.6%. The business is scheduled to report its next earnings results on Thursday, March 14th.

According to Zacks, analysts expect that U.S. Physical Therapy will report full-year earnings of $2.54 per share for the current fiscal year, with EPS estimates ranging from $2.49 to $2.57. For the next year, analysts forecast that the business will report earnings of $2.77 per share, with EPS estimates ranging from $2.62 to $2.90. Zacks’ EPS averages are a mean average based on a survey of research analysts that follow U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The business had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $112.79 million. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year.

USPH has been the subject of several analyst reports. Jefferies Financial Group restated a “hold” rating and set a $105.00 price target on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. TheStreet cut U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Cantor Fitzgerald upped their price target on U.S. Physical Therapy from $103.00 to $107.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 price target for the company in a research note on Tuesday, August 7th. Finally, Barrington Research restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Four analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $113.67.

U.S. Physical Therapy stock opened at $114.96 on Friday. U.S. Physical Therapy has a 12 month low of $68.25 and a 12 month high of $129.65. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 1.93. The company has a market cap of $1.50 billion, a PE ratio of 55.27, a P/E/G ratio of 4.10 and a beta of 1.19.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Friday, November 9th will be issued a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.

In related news, Director Mark J. Brookner sold 625 shares of the company’s stock in a transaction on Friday, September 7th. The stock was sold at an average price of $128.50, for a total transaction of $80,312.50. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Lawrance W. Mcafee sold 3,100 shares of the company’s stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $113.29, for a total value of $351,199.00. The disclosure for this sale can be found here. Insiders have sold 12,600 shares of company stock worth $1,460,099 in the last ninety days. 2.50% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. grew its holdings in U.S. Physical Therapy by 11.5% during the third quarter. BlackRock Inc. now owns 1,950,274 shares of the company’s stock worth $231,302,000 after acquiring an additional 201,866 shares during the period. Renaissance Technologies LLC grew its holdings in U.S. Physical Therapy by 4.6% in the second quarter. Renaissance Technologies LLC now owns 653,100 shares of the company’s stock valued at $62,698,000 after purchasing an additional 28,600 shares during the last quarter. BTIM Corp. acquired a new stake in U.S. Physical Therapy in the second quarter valued at $21,417,000. Northern Trust Corp grew its holdings in U.S. Physical Therapy by 10.3% in the second quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock valued at $20,903,000 after purchasing an additional 20,295 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in U.S. Physical Therapy by 3.1% in the third quarter. Bank of New York Mellon Corp now owns 185,318 shares of the company’s stock valued at $21,979,000 after purchasing an additional 5,527 shares during the last quarter. 98.45% of the stock is currently owned by hedge funds and other institutional investors.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: Technical Analysis

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.